NCT00381667View on ClinicalTrials.gov

Study to Assess GW642444 in Asthma Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

GW642444M

M salt

DRUG

GW642444H

H salt

OTHER

placebo

placebo

Trial Locations (2)

3168

GSK Investigational Site, Clayton

6001

GSK Investigational Site, Wellington

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00381667 - Study to Assess GW642444 in Asthma Patients | Biotech Hunter | Biotech Hunter